34
Participants
Start Date
June 30, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
May 30, 2028
BAY3723113
Oral tablet
NOT_YET_RECRUITING
Kurume University Hospital, Kurume
RECRUITING
Hyogo Prefectural HarimaHimeji General Medical Center, Himeji
RECRUITING
Kobe City Medical Center General Hospital, Kobe
RECRUITING
University of Tsukuba Hospital, Tsukuba
RECRUITING
Iwate Prefectural Central Hospital, Morioka
RECRUITING
Kitasato University Hospital, Sagamihara
RECRUITING
SHOWA Medical University Fujigaoka Hospital, Yokohama
NOT_YET_RECRUITING
Kochi Medical School Hospital, Nankoku
NOT_YET_RECRUITING
Mie University Hospital, Tsu
NOT_YET_RECRUITING
Tohoku University Hospital, Sendai
RECRUITING
Saiseikai Kumamoto Hospital, Kumamoto
NOT_YET_RECRUITING
Kurashiki Central Hospital, Kurashiki
NOT_YET_RECRUITING
University of the Ryukyus Hospital, Ginowan
RECRUITING
Matsushita Memorial Hospital, Moriguchi
NOT_YET_RECRUITING
National Cerebral and Cardiovascular Center, Suita
RECRUITING
The University of Osaka Hospital, Suita
NOT_YET_RECRUITING
Hamamatsu University Hospital, Hamamatsu
RECRUITING
Nippon Medical School Hospital, Bunkyo-ku
NOT_YET_RECRUITING
The University of Tokyo Hospital, Bunkyo
RECRUITING
Sakakibara Heart Institute, Fuchū
RECRUITING
Showa Medical University Koto Toyosu Hospital, Koto
RECRUITING
Saiseikai Fukuoka General Hospital, Fukuoka
NOT_YET_RECRUITING
Gifu University Hospital, Gifu
NOT_YET_RECRUITING
Kumamoto University Hospital, Kumamoto
RECRUITING
University Hospital, Kyoto Prefectural University of Medicine, Kyoto
Lead Sponsor
Bayer
INDUSTRY